Equity Profile

ARE

Alexandria Real Estate Equities, Inc.

Real EstateHealth Care REITs$8.3B

Aug3Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on developing and managing properties for the life sciences and healthcare sectors....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and will help gauge financial health this quarter.

$0.12

Revenue

Revenue figures will provide insight into the company's operational performance and demand for its properties.

$656M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARE Q2-2026 Earnings Preview

Context

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on developing and managing properties for the life sciences and healthcare sectors. With a market cap of $8 billion, it plays a crucial role in supporting innovation and research in health care through its specialized facilities.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-10.19%

Avg Stock Reaction

-0.85%

Last Quarter Recap

In Q1-2026, Alexandria reported an EPS of $1.73, matching analyst expectations. However, the stock fell by 3.88% the following day, indicating market disappointment despite meeting estimates.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Alexandria to report modest earnings and revenue this quarter, with a consensus EPS of $0.12 and revenue of $656 million. The market is closely watching how the company navigates the current economic environment.

Bull Case

If Alexandria exceeds expectations, particularly in revenue growth, it could signal strong demand for its properties in the healthcare sector, potentially driving the stock higher.

Bear Case

Conversely, if the company misses earnings or revenue targets, it may raise concerns about its growth prospects, leading to further declines in stock price.

Key Metrics to Watch

EPS

$0.12

Earnings per share (EPS) is a key indicator of the company's profitability and will help gauge financial health this quarter.

Revenue

$656M

Revenue figures will provide insight into the company's operational performance and demand for its properties.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Alexandria's revenue exceed the consensus estimate of $656 million?

Revenue performance is critical to understanding the demand for its properties and overall business health.

How will management address the recent trends in EPS performance?

Given the company's history of missing EPS estimates, clarity on future expectations will be crucial for investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth driven by increased demand for healthcare facilities, particularly as the sector rebounds post-pandemic.

Supporting Evidence

The options market is pricing a significant move, indicating heightened expectations that may not align with current consensus.

Alexandria's strategic focus on life sciences positions it uniquely to capitalize on ongoing healthcare trends.

Key Risk

If revenue significantly exceeds $656 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows a series of earnings misses, raising questions about the company's ability to rebound.

Bull Confirmed If

A revenue figure above $656 million would confirm strong demand and growth potential.

Bear Confirmed If

An EPS below $0.12 would reinforce concerns about the company's profitability and growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±21.34%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±21.3% while ARE has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

52.1%

Calls (288K)P/C Ratio: 0.49Puts (1.1M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alexandria beats expectations, history suggests a potential average one-day move of +1.64%, confirming a bullish outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average one-day drop of -0.58% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new property developments or acquisitions in the healthcare sector.
2Management's commentary on demand trends for life sciences real estate.
3Insights into how the company plans to address recent EPS performance issues.
4Details on tenant retention rates and new leases signed.
5Any guidance on future revenue expectations or market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) focused on developing and managing properties for the life sciences and healthcare sectors....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and will help gauge financial health this quarter.

$0.12

Revenue

Revenue figures will provide insight into the company's operational performance and demand for its properties.

$656M

Wall Street expectations, options signals, track record, and call prep available with Pro.

ARE Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-10.19%

Avg Stock Reaction

-0.85%

Last Quarter Recap

In Q1-2026, Alexandria reported an EPS of $1.73, matching analyst expectations. However, the stock fell by 3.88% the following day, indicating market disappointment despite meeting estimates.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Alexandria exceeds expectations, particularly in revenue growth, it could signal strong demand for its properties in the healthcare sector, potentially driving the stock higher.

Bear Case

Conversely, if the company misses earnings or revenue targets, it may raise concerns about its growth prospects, leading to further declines in stock price.

Key Metrics to Watch

EPS

$0.12

Earnings per share (EPS) is a key indicator of the company's profitability and will help gauge financial health this quarter.

Revenue

$656M

Revenue figures will provide insight into the company's operational performance and demand for its properties.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Alexandria's revenue exceed the consensus estimate of $656 million?

Revenue performance is critical to understanding the demand for its properties and overall business health.

How will management address the recent trends in EPS performance?

Given the company's history of missing EPS estimates, clarity on future expectations will be crucial for investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth driven by increased demand for healthcare facilities, particularly as the sector rebounds post-pandemic.

Supporting Evidence

The options market is pricing a significant move, indicating heightened expectations that may not align with current consensus.

Alexandria's strategic focus on life sciences positions it uniquely to capitalize on ongoing healthcare trends.

Key Risk

If revenue significantly exceeds $656 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it follows a series of earnings misses, raising questions about the company's ability to rebound.

Bull Confirmed If

A revenue figure above $656 million would confirm strong demand and growth potential.

Bear Confirmed If

An EPS below $0.12 would reinforce concerns about the company's profitability and growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±21.34%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±21.3% while ARE has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

52.1%

Calls (288K)P/C Ratio: 0.49Puts (1.1M)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Alexandria beats expectations, history suggests a potential average one-day move of +1.64%, confirming a bullish outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average one-day drop of -0.58% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new property developments or acquisitions in the healthcare sector.
2Management's commentary on demand trends for life sciences real estate.
3Insights into how the company plans to address recent EPS performance issues.
4Details on tenant retention rates and new leases signed.
5Any guidance on future revenue expectations or market conditions.